Disturbi alimentari e GLP-1 agonisti Nellambito dei DCA, la ricerca ha iniziato a indagare la possibilit che i farmaci GLP-1 agonisti possano essere utilizzati, in certi casi, anche per il trattamento di disturbi dellalimentazione
Despite these challenges, orlistat is acknowledged for its effectiveness in weight management and its potential for anti-cancer research, mainly attributed to its role as a gastrointestinal lipase inhibitor that limits dietary fat absorption [39, 41, 42]
Novel Multi-Ingredient Supplement Facilitates Weight Loss and Improves Body Composition in Overweight and Obese Individuals: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Niemals einfrieren-auftauen wiederholen jeder Zyklus reduziert die Wirkstoffintegritt
Gastroduodenal (sucrose excretion) (79) and whole gut permeability ( 51 Cr-EDTA) (80) were also increased in patients with active CeD
PMID: 1362956